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Abstract
Left ventricular hypertrophy (LVH) represents a common final pathway leading to heart fail-
ure. We have searched for genetic determinants of left ventricular (LV) mass using values
for absolute electrocardiographic QRS voltage in a healthy Japanese population. After
adjusting for covariates, the corrected S and R wave voltages in leads V1 and V5 from
2,994 healthy volunteers in the Japan Pharmacogenomics Data Science Consortium
(JPDSC) database were subjected to a genome-wide association study. Potential associa-
tions were validated by an in silico replication study using an independent Japanese popu-
lation obtained from the Nagahama Prospective Genome Cohort for Comprehensive
Human Bioscience. We identified a novel association between the lead V5, R wave voltage
in Japanese individuals and SNP rs7301743[G], which maps near the gene encoding T-
box transcription factor Tbx3. Meta-analysis of two independent Japanese datasets demon-
strated a marginally significant association of SNP rs7301743 in TBX3|MED13L with a
0.071 mV (95% CI, 0.038–0.11 mV) shorter R wave amplitude in the V5 lead per minor
allele copy (P = 7.635 x 10−8). The transcriptional repressor, TBX3, is proposed to suppress
the development of working ventricular myocardium. Our findings suggest that genetic vari-
ation of Tbx3 is associated with LV mass in a healthy Japanese population.
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Introduction
Left ventricular hypertrophy (LVH) represents a common final pathway leading to heart failure
[1], and is associated with an increased vulnerability to sudden death and acute myocardial
infarction [2]. Left ventricular (LV) mass can be regarded as a quantitative trait that is affected
by both environmental and genetic factors that vary considerably between individuals. The
search for genes conferring an individual's genetic susceptibility to LVH is clinically relevant.
Early diagnosis through identification of genetic polymorphisms indicative of disease, along
with subsequent intervention, has the potential to bring about a new era of preemptive medi-
cine for cardiovascular diseases.
It is not realistic to expect an ECG to diagnose LVH with more than a modest degree of
accuracy [3]. Nevertheless, epidemiological research has demonstrated that electrocardio-
graphically diagnosed LVH (ECG-LVH) carries significant prognostic value [4]. Consistent
with this, recent genome-wide association studies (GWAS) and genome-wide linkage analysis
have shown that ECG-LVH provides unique information about the genetic determinants of
LVH [5] [6] [7].
Previous GWAS for ECG-LVH were designed to compare cases of ECG-LVH with controls.
Logistic regression tested for associations between SNPs and the case-control status. ECG-LVH
is largely dependent on fixed voltage thresholds. Using these measures, individuals with mild
LVHmay fail to fulfil the criteria for a diagnosis of LVH. Indeed, defining LVH as a qualitative
trait using fixed voltage criteria risks losing valuable information contained in the magnitude
of QRS voltages.
In this study, we have therefore investigated genetic determinants of LV mass in a healthy
Japanese population by a GWAS using absolute QRS voltage.
Material and Methods
JPDSC
The Japan Pharmacogenomics Data Science Consortium (JPDSC) is comprised of six pharma-
ceutical companies: Astellas, Daiichi Sankyo, Mitsubishi Tanabe, Otsuka, Taisho, and Takeda.
The JPDSC maintains a database of 2,994 healthy Japanese volunteers for pharmacogenomics
(PGx) studies, which contains the genotypes of 2.5 million single-nucleotide polymorphisms
(SNPs) and 5 human leukocyte antigen loci per person, as well as other clinical information,
such as physiological, haematological, and biochemical data. The data set was obtained in two
phases. The first data set was collected between 2000 and 2003, with the remaining data set
gathered in a second phase from 10 geographic regions in Japan. Sample collection was vali-
dated by the principal component analysis. All subjects gave written informed consent, and we
obtained ethical approval for the study from the ethics committee of JPDSC (Ichiro Matsuda,
Ryuichi Ida, Yayoi Sasaki, Sumio Sugano, Eiko Suda, Masashi Tokunaga, Toru Masui, Kaori
Muto) [8].
Statistical analysis for GWAS
Genomic DNAs were genotyped on an Illumina Human Omn 2.5.8 BeadChip. SNPs that met
the following criteria were used in the GWAS: SNP call rates ( 95%), the Hardy-Weinberg
equilibrium test (P 0.01), and minor allele frequency ( 1%). We used linear regression to
adjust ECG measures for independent variables within each phase. In each phase, we combined
the standardised residuals and used them as quantitative phenotypes for the association analy-
sis with PLINK (version 1. 1. 3). We evaluated if a trait and genotype were significantly associ-
ated using Wald test [9].
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Replications and Meta Analysis
Replication of candidate SNPs was tested using datasets obtained from the Nagahama Prospec-
tive Genome Cohort for Comprehensive Human Bioscience (the Nagahama Study [n = 2941])
a community-based prospective multiomics cohort study conducted by Kyoto University. The
covariates used for the correction in the replication study included age, sex, log HR, and sys-
tolic pressure of participants (i.e. Nagahama city). Genomic DNAs were genotyped on an Affy-
metrix 5.0 SNP array. We replicated 13 different associations, thus the P-value threshold of
0.05/13 = 0.0038 was used according to Bonferroni’s correction [10]. Meta-analysis was per-
formed using the inverse variance method by using R environment (version 2.15.0).
The JPDSC data (the allele frequency data from about 1.4M SNP of all 2994 Japanese
healthy volunteers and each birth place region) and individual genotype data of the Nagahama
cohort participants are now available in the National Bioscience Database Center, http://
humandbs.biosciencedbc.jp/.
Results
Clinical and electrocardiographic characteristics of JPDSC data set
For statistical analysis, we used phase 1 JPDSC dataset of 992 healthy Japanese volunteers (596
males and 396 females) and phase 2 JPDSC dataset of 2,002 healthy Japanese volunteers (998
males and 1,004 females). The mean, median, minimum, and maximum of clinical parameters
[age, body mass index (BMI), heart rate, systolic and diastolic blood pressure, serum potas-
sium, and serum calcium] and electrocardiographic LV voltages [RV5 = R wave in V5 (mV),
SV1 = S wave in V1 (mV), RV5 + SV1 = the sum of RV5 + SV1 (mV)] are summarized in
Table 1.
Clinical factors accounting for variations in ECG LV voltages
To examine the variation in electrocardiographic LV voltages between individuals, we first
used multiple linear regression analysis to evaluate the effects of non-genetic factors (S1 Table).
Outliers, defined as values four standard deviations higher or lower than the mean, were
removed (S1 Fig).
We tested whether gender, age, log-transformed (log) BMI, log heart rate (HR), systolic
pressure, diastolic pressure, serum potassium, serum calcium, and Japanese geographic region
should be included as covariates. Based on these preliminary results, we used: age, gender, log
HR, and systolic pressure as covariates for log RV5; age, gender, log BMI, and systolic pressure
as covariates for log SV1; and age, gender, log BMI, log (HR), and systolic pressure as covariates
for log (RV5+SV1).
Possible novel loci associated with ECG LV voltages
After adjusting for non-genetic covariates, corrected electrocardiographic LV voltages (cor-
rected RV5, corrected SV1, corrected RV5+SV1) were subjected to GWAS (Fig 1, S2 Fig).
SNPs associated with RV5 and SV1 were not the same. Based on the Manhattan plots and
quantile-quantile plots of genome-wide association results, we focused on loci associated with
amplitude of the R wave in V5. The results of the GWAS on RV5 are summarized in Fig 1.
Using a pre-specified P value threshold of 1 X 10−5, we searched for genetic loci harbouring
significant SNPs associated with RV5. SNPs below the threshold of P value< 10−4 and located
in genes of interest were also included. We selected 13 SNPs based on a quality assessment sur-
vey of SNP genotyping and clarity of cluster (Table 2), and performed a replication study using
an independent Japanese population obtained from the Nagahama Prospective Cohort for
Genetic Determinants of Left Ventricular Mass
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Comprehensive Human Bioscience (the Nagahama Study) (n = 2941). SNP rs7301743, which
maps near TBX3, was replicated (Table 3).
Meta-analysis of two Japanese datasets for possible novel associations
To obtain P values based on the results from two independent Japanese datasets, we performed
a meta-analysis by the inverse variance method (Table 4). We observed a highly significant
association of SNP rs7301743 in TBX3|MED13L with a 0.071 mV (95% CI, 0.038–0.11 mV)
smaller voltage of the R wave in V5 per minor allele copy (P = 7.635 X 10−8). This SNP was
located upstream of the coding region of TBX3 (S3 Fig).
Discussion
In healthy subjects from the JPDSC datasets, there was only a modest correlation between SV1
and RV5, both of which have been used as indices of LVH according to the Sokolow-Lyon cri-
teria [11]. We have demonstrated that the voltage of the S wave in V1 (SV1), and that of the R
wave in V5 (RV5) are differently affected by both non-genetic and genetic factors. Therefore,
simply adding the S wave in V1 to the R wave in V5 may not be appropriate. We observed volt-
age attenuation of SV1 with advancing age, while the RV5 voltage was only modestly affected
by age. The degree of obesity, as measured by BMI, was inversely correlated with the magnitude
of SV1 in both sexes. By contrast, RV5 was less affected by BMI. Increased HR attenuated RV5,
but not SV1, in both sexes. Comparison of the quantile–quantile plots (Q–Q plots) for SV1 and
RV5 suggested that the RV5 was more strongly affected by genetic factors than the SV1. SNPs
associated with RV5 and those associated with SV1 were not the same. The present GWAS
Table 1. Characteristics of participants in JPDSC.
Qualitative Variable Phase Levels Size
Gender Phase 1 Male/Female 596/396 (Total 992)
Phase 2 Male/Female 998/1004 (Total 2002)
Quantitative Variable Phase Mean SD Min. 1st Q. Median 3rd Q. Max.
Age (years) Phase 1 38.76 11.67 20 29 36 46 74
Phase 2 33.40 9.94 20 26 32 38 75
BMI (kg/m2) Phase 1 22.31 2.00 16 20.22 22 23.9 37.4
Phase 2 21.94 3.39 14.1 19.6 21.3 23.7 45.1
Systole (mmHg) Phase 1 127.20 2.00 84 114 124 138 199
Phase 2 118.70 15.62 77 108 117 128 198
Diastole (mmHg) Phase 1 78.69 2.00 39 70 77 86 125
Phase 2 72.38 11.24 40 64 71 80 123
HR (bpm) Phase 1 74.56 5.00 43 67 74 81 126
Phase 2 67.18 10.13 34 60 66 73 115
K (mEQ/L) Phase 1 3.56 1.00 2.5 3.4 3.6 3.7 4.7
Phase 2 4.11 1.00 3 3.9 4.1 4.3 19.6
Ca (mg/dL) Phase 1 9.38 1.00 7.9 9.1 9.4 9.6 10.9
Phase 2 9.48 1.00 7.9 9.2 9.5 9.7 13.4
RV5 Phase 1 1.68 5.00 0.325 1.275 1.62 1.993 3.97
Phase 2 1.47 0.53 0.03 1.09 1.4 1.75 4.7
SV1 Phase 1 1.05 5.00 0 0.7325 1.01 1.3 3.25
Phase 2 1.00 1.00 0.05 0.69 0.94 1.25 3.2
RV5+SV1 Phase 1 2.73 6.00 0.75 2.205 2.625 3.205 5.705
Phase 2 2.47 0.78 0.72 1.91 2.4 2.92 7.55
doi:10.1371/journal.pone.0155550.t001
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study using the JPDSC dataset identified that only the IQCA1 gene locus was associated with
both adjusted RV5 and SV1 voltages (p-values< 1 x 10−3).
We found that SNPs in the genes CTNNA3, MYL2, TBX3, ZFHX3, HDAC4, KCE4, and
HERG were associated with the magnitude of the RV5 voltage. CTNNA3 encodes a protein
belonging to the alpha-catenin family that plays a cell-cell adhesion role in cardiac muscle cells.
Mutations in this gene are associated with arrhythmogenic right ventricular dysplasia [12].
MYL2 encodes a regulator protein of ventricular myosin ATPase activity and a mutation in
this gene is associated with hypertrophic cardiomyopathy phenotype [13]. The zinc finger
Fig 1. The results of GWAS on corrected electrocardiographic RV5 voltages. The Manhattan plots and
quantile-quantile plots of genome-wide association results for RV5 from analysis of JPDSC datasets are shown.
doi:10.1371/journal.pone.0155550.g001
Table 2. Results of GWAS for R wave in V5.
SNPID CHR POS GENE Minor/Major MAF Coefﬁcient P
rs2395983 2 224267984 KCNE4|SCG2 C/A 0.27 -0.066 2.63E-07
rs1921643 2 224294501 KCNE4|SCG2 A/G 0.251 -0.061 3.19E-06
rs1108519 2 240311883 HDAC4 G/A 0.182 0.064 3.39E-05
rs12613544 2 240327465 HDAC4|FLJ45964 G/A 0.172 0.067 1.94E-05
rs3733008 3 186387779 HRG G/A 0.054 -0.113 6.08E-06
rs10430513 10 69410048 CTNNA3 A/G 0.259 -0.074 1.37E-08
rs10783539 12 53204757 KRT4 A/G 0.189 -0.073 8.14E-07
rs4766515 12 111308801 CCDC63 G/A 0.194 -0.077 1.24E-07
rs2301610 12 111353556 MYL2 G/A 0.207 -0.068 2.16E-06
rs7301743 12 115344561 TBX3|MED13L G/A 0.408 -0.047 5.11E-05
rs12929452 16 72838680 ZFHX3 A/G 0.092 -0.091 5.12E-06
rs8131653 21 45644684 LOC100129890|ICOSLG G/A 0.038 -0.131 7.93E-06
rs9977816 21 45653614 ICOSLG G/A 0.039 -0.128 8.12E-06
doi:10.1371/journal.pone.0155550.t002
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homeobox 3 (ZFHX3) gene encodes a transcription factor highly expressed in the heart and its
genetic variants are associated with atrial fibrillation susceptibility [14]. HDAC4 encodes a
class II histone deacetylase that modulates cardiac hypertrophic responses via epigenetic modi-
fications [15]. KCNE4 and HERG encode potassium channels. Changes in potassium channel
function are associated with cardiac hypertrophy [16]. Further studies are required to replicate
these SNP associations.
Our GWAS and the subsequent validation study identified a novel association of SNP
rs7301743[G], which maps near the T-box transcription factor Tbx3 gene, with the R-wave
voltage in the V5 lead of Japanese individuals. Members of the T-box (TBX) family of tran-
scription factors have been identified as crucial players in various aspects of multi-chambered
mammalian heart development, including cardiac lineage determination, chamber specifica-
tion, valvuloseptal development, and diversification of the specialized conduction system in
vertebrate embryos [17]. TBX1, TBX2, TBX3, TBX5, TBX18, and TBX20 are expressed in the
mammalian heart, and all exhibit complex temporal and spatial regulation in developing
cardiac structures. TBX1 and TBX20 promote development of the outflow tract and right
Table 3. Replication study for R wave in V5.
SNP ID CHR POS GENE Minor/Major MAF Coefﬁcient P
rs2395983 2 224267984 KCNE4|SCG2 C/A 0.269 -0.001 9.35E-01
rs1921643 2 224294501 KCNE4|SCG2 A/G 0.245 -0.004 7.32E-01
rs1108519 2 240311883 HDAC4 G/A 0.193 -0.019 1.34E-01
rs12613544 2 240327465 HDAC4|FLJ45964 G/A 0.181 -0.017 2.12E-01
rs3733008 3 186387779 HRG G/A 0.06 -0.033 1.13E-01
rs10430513 10 69410048 CTNNA3 A/G 0.262 0.003 7.98E-01
rs10783539 12 53204757 KRT4 A/G 0.189 0.018 1.69E-01
rs4766515 12 111308801 CCDC63 G/A 0.218 0.012 3.17E-01
rs2301610 12 111353556 MYL2 G/A 0.229 0.01 4.37E-01
rs7301743 12 115344561 TBX3|MED13L G/A 0.427 -0.036 4.47E-04
rs12929452 16 72838680 ZFHX3 A/G 0.071 -0.009 6.59E-01
rs8131653 21 45644684 LOC100129890|ICOSLG G/A 0.032 -0.036 5.84E-01
rs9977816 21 45653614 ICOSLG G/A 0.032 -0.024 4.15E-01
doi:10.1371/journal.pone.0155550.t003
Table 4. Meta-analysis for R wave in V5.
SNP CHR POS GENE Coefﬁcient SE P
rs2395983 2 224267984 KCNE4|SCG2 -0.022 0.007 2.27E-03
rs1921643 2 224294501 KCNE4|SCG2 -0.03 0.009 4.75E-04
rs1108519 2 240311883 HDAC4 0.014 0.01 1.55E-01
rs12613544 2 240327465 HDAC4|FLJ45964 0.017 0.01 8.96E-02
rs3733008 3 186387779 HRG -0.068 0.016 1.63E-05
rs10430513 10 69410048 CTNNA3 -0.033 0.009 1.43E-04
rs10783539 12 53204757 KRT4 -0.024 0.01 1.50E-02
rs4766515 12 111308801 CCDC63 -0.027 0.009 4.39E-03
rs2301610 12 111353556 MYL2 -0.024 0.009 8.12E-03
rs7301743 12 115344561 TBX3|MED13L -0.041 0.008 7.64E-08
rs12929452 16 72838680 ZFHX3 -0.051 0.014 2.32E-04
rs8131653 21 45644684 LOC100129890|ICOSLG -0.116 0.026 5.69E-06
rs9977816 21 45653614 ICOSLG -0.079 0.02 7.00E-05
doi:10.1371/journal.pone.0155550.t004
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ventricular myocardium, while TBX5 promotes development of left ventricular myocardium.
TBX2 and TBX3 trigger development of endocardial cushions, the precursors of the atrioven-
tricular septum, valves, and conduction system, while suppressing development of the working
ventricular myocardium.
Meta-analysis of two independent Japanese datasets demonstrated a highly significant asso-
ciation of SNP rs7301743 in TBX3|MED13L with a 0.071 mV (95% CI, 0.038–0.11 mV) shorter
amplitude of the R wave in the V5 lead per minor allele copy (P = 7.635 X 10−8). Since TBX3 is
able to suppress a large panel of working myocardial genes in the fully differentiated working
myocardium [18], we speculate that genetic mutations alter temporal and spatial regulation of
TBX3 expression, thereby affecting LV free wall mass under steady-state conditions or chang-
ing LVH susceptibility.
Our approach has resulted in the detection of novel genetic factors associated with LV mass,
and may be compared with the widely used method of detecting LVH by fixed voltage criteria.
Differences between this study and previous studies are in part due to selection bias. Previous
studies enrolled more pathologically extreme LVH encountered in a hospital-based cohort.
This study is based on a primarily healthy population.
The present study has some limitations. First, our retrospective study evaluated left ventric-
ular mass by ECG because it was a standard diagnostic method. Estimates by ECG, however,
are less accurate than estimates by cardiac MRI. Second, meta-analysis of two independent Jap-
anese datasets demonstrated that association of SNPs in TBX3 with the RV5 voltage variation
was the most significant, however, did not reach the genome-wide significance threshold
(P 5 × 10−8). Third, in GWAS studies, associated SNPs are often in the non-coding region.
Whether the associated SNPs really affect the phenotype (in this case, LVH) is often argued but
confirmatory explanation is often difficult. If there are eQTL data for human heart, we may
able to test whether the associated SNP changes the mRNA of a gene but this was not possible
in our study.
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